semaglutide and non alcoholic fatty liver disease Why are GLP-1 agonists being used to treat patients with nonalcoholic disease? Semaglutide (Ozempic/Wegovy) dramatically improves fatty

The researchers aimed to perform a secondary analysis of the LEADER trial, a randomized, double blind, placebo controlled trial, which investigated the differences in incidence of cardiovascular death, myocardial infarction and stroke between adults who received liraglutide or placebo for the treatment of type 2 diabetes

Among drinks, the undisputed leader is the legendary milk tea thick, aromatic, and invigorating

10.1093/ajcn/nqaa095 2

However large scale, robust studies in humans are needed, while it is unclear if such drugs dampen reward signalling generally in the brain raising concerns around their use in people with depression

Combined global sales of GLP-1 RAs exceeded tens of billions in 2025, fueling massive profitability for the developers